ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976

B.J. Kennedy, “Father of Medical Oncology,” Dead At 81

April 18, 2003

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997